Kevin Ackhurst
Norton Rose Fulbright
Articles
At a glance: pharmaceutical merger review in Canada
Canada - June 30 2020 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in Canada, including review triggers and thresholds.
Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in Canada
Canada - June 30 2020 A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Canada, including IP rights abuse and pricing conduct.
Anticompetitive unilateral conduct in the pharmaceutical sector in Canada
Canada - September 6 2019 An overview of practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Canada, including IP rights abuse and pricing conduct.
Bradley Schneider, Erin Brown, Ian Trimble, Stephen Nattrass.
Anticompetitive agreements in the pharmaceutical sector in Canada
Canada - September 6 2019 An overview of essential considerations surrounding anticompetitive agreements in the pharmaceutical sector in Canada, including the assessment framework and special issues with vertical agreements.
Bradley Schneider, Erin Brown, Ian Trimble, Stephen Nattrass.
Pharmaceutical antitrust law in Canada
Canada - September 6 2019 A structured guide to antitrust law in the pharmaceutical sector in Canada, including the legislative and regulatory framework, merger review, anticompetitive agreements and abuse of dominance.
Bradley Schneider, Erin Brown, Ian Trimble, Stephen Nattrass.
